Login
$MMSI
$86.35 -$0.28 (0.32%) Live

$MMSI 8-K/A SEC Filings

Filed On Filing
28 Feb 2023 8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure

Q4 2022 reported revenue of $293.4 million, up 5.4% compared to Q4 2021

01 Sep 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

an attorney or other counsel of your choice prior to signing this Agreement.

04 Jun 2018 8-K/A: Submission of Matters to a Vote of Security Holders

On May 31, 2018, Merit Medical Systems, Inc. (the “Company”) filed with the U.S. Securities and Exchange Commission a Current Report on Form 8-K (the "Initial Report"). Among other items set forth in the Initial Report was Item 5.07, whi...

27 Apr 2018 8-K/A: Results of Operations and Financial Condition

(801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688

24 Feb 2017 8-K/A: Financial Statements and Exhibits

(801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688

21 Sep 2016 8-K/A: Financial Statements and Exhibits

We have audited the accompanying consolidated financial statements of DFINE, Inc. and its subsidiary, which comprise the consolidated balance sheets as of December 31, 2015 and 2014, and the related consolidated statements of comprehensi...

28 Jul 2016 8-K/A: Regulation FD Disclosure

1 2nd Quarter 2016 Results FRED LAMPROPOULOS Chairman & CEO BERNARD BIRKETT CFO

08 Feb 2016 8-K/A: Departure/Election of Directors or Officers; Compensation

On November 6, 2015, Merit Medical Systems, Inc. (the “Company”) filed with the Securities and Exchange Commission a Current Report on Form 8-K (the “Initial Report”) for the purposes, among others, of reporting the removal of Kent Stang...

12 Jan 2016 8-K/A: Departure/Election of Directors or Officers; Compensation

On December 7, 2015, Merit Medical Systems, Inc. (the “Company”) filed with the Securities and Exchange Commission a Current Report on Form 8-K (the “Initial Report”) for the purpose of reporting the separation of Rashelle Perry, formerl...

04 May 2015 8-K/A: Departure/Election of Directors or Officers; Compensation

On April 20, 2015, Merit Medical Systems, Inc. (the “Company”) filed with the Securities and Exchange Commission a Current Report on Form 8-K (the “Initial Report”) for the purpose of reporting the retirement of Martin R. Stephens, forme...

04 Mar 2014 8-K/A: Regulation FD Disclosure

Fred Lampropoulos Merit Medical Systems Inc - Chairman & CEO

29 Mar 2013 8-K/A: Financial Statements and Exhibits

CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO RULE 24B-2 AND ARE SUBJECT TO A CONFIDENTIAL TREATMENT REQUEST. COPIES OF THIS EXHIBIT CONTAINING THE OMITTED INFORMATION HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND E...

07 Mar 2013 8-K/A: Financial Statements and Exhibits

Financial Statements for the Nine Months Ended September 30, 2012 and 2011 (Unaudited) and Year Ended December 31, 2011, and Independent Auditors’ Report

24 Jan 2013 8-K/A: Financial Statements and Exhibits

CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO RULE 24B-2 AND ARE SUBJECT TO A CONFIDENTIAL TREATMENT REQUEST. COPIES OF THIS EXHIBIT CONTAINING THE OMITTED INFORMATION HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND E...

30 Nov 2012 8-K/A: Financial Statements and Exhibits

CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO RULE 24B-2 AND ARE SUBJECT TO A CONFIDENTIAL TREATMENT REQUEST. COPIES OF THIS EXHIBIT CONTAINING THE OMITTED INFORMATION HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND E...

23 Dec 2010 8-K/A: Financial Statements and Exhibits

On September 10, 2010, we completed the acquisition of BioSphere pursuant to an Agreement and Plan of Merger dated May 13, 2010 by and among Merit Medical Systems, Inc., Merit BioAcquisition Co., and BioSphere Medical, Inc. (the “Merger ...

22 Nov 2010 8-K/A: Financial Statements and Exhibits

On September 10, 2010, we completed the acquisition of BioSphere pursuant to an Agreement and Plan of Merger dated May 13, 2010 by and among Merit Medical Systems, Inc., Merit BioAcquisition Co., and BioSphere Medical, Inc. (the “Merger ...

16 Sep 2010 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more

Existing Non-Credit Party Unsecured Intercompany Indebtedness

02 Jun 2010 8-K/A: Entry into a Material Definitive Agreement

THIS AMENDMENT NO. 1 TO STOCKHOLDER AND VOTING AGREEMENT (this “Amendment”), dated as of June 1, 2010, is made and entered into among Merit Medical Systems, Inc., a Utah corporation (the “Buyer”), and Cerberus Partners, L.P. and Cerberus...

14 May 2010 8-K/A: Entry into a Material Definitive Agreement

THIS STOCKHOLDER AND VOTING AGREEMENT (this “Agreement”), dated as of May 13, 2010, is made and entered into among Merit Medical Systems, Inc., a Utah corporation (the “Buyer”), and Cerberus Partners, L.P. and Cerberus International, Ltd...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support